Quest Diagnostics - 2021 Corporate Responsibility Report

Quest Diagnostics - 2021 Corporate Responsibility Report

As the world’s leading provider of diagnostic insights, we are refining and enhancing our approach to corporate responsibility to drive stronger alignment of our business to our evolving society. We believe that building upon our established programs and further expanding the scope of our efforts will enable us to create additional, long-term, sustainable value.

Throughout 2022, we will continue to sharpen our focus areas and establish goals aligned with our overall business strategy and stakeholder concerns.

Read the full report here.

Content from this campaign

Expanding the Possibilities With Quest Advanced® Neurology
Quest Advanced® Neurology offers a complete neurological testing portfolio, including molecular, biochemical, neuroimmunological, cytogenetic, and pharmacogenomic testing for diagnosing neurological conditions. Our broad menu of over 400 neurology tests is powered by 15 distinct methodologies, providing transformative answers. Our 650+ medical experts provide consultation on next steps for...
Nov 30, 2022 12:55 PM ET
Improving Outcomes for the Leading Cause of Death in the US
New biomarkers offer pathways to prevention Quest has expanded from our original primary focus on heart disease to a multi-pronged proactive approach that focuses on critical diagnostic insights across the cardiometabolic continuum. This unique interconnected approach ensures that healthcare providers have a complete survey of a patient’s cardiometabolic health and...
Nov 16, 2022 10:40 AM ET
Key Insights on Current and Emerging Healthcare Issues
The Quest Diagnostics Health Trends® series of reports are drawn from our billions of data points to provide key insights into current healthcare issues. Health Trends reports in 2020 and 2021 have focused on important insights gained during the first years of the COVID-19 pandemic, including identifying significant declines in routine cancer screenings1 as well as in recommended...
Oct 25, 2022 11:15 AM ET
Thought Leadership Marries Insights to Influence
In addition to serving about half of hospitals and physicians and approximately 1 in 3 adults each year in the US, Quest Diagnostics has become a recognized thought leader and innovator in COVID-19 research and services. Our original research and critical insights are highlighting the many unanticipated impacts of the pandemic on public health. Additionally, through Q4HE, we have taken...
Oct 13, 2022 10:30 AM ET
Working With the CDC and Others To Advance Understanding of SARS-CoV-2
“Public and private collaboration is essential to mobilizing an effective response to COVID-19.” Jay G. Wohlgemuth, MD Chief Medical Officer, Senior Vice President, Research & Development In 2021, Quest labs continued to work with the Centers for Disease Control and Prevention (CDC) on genomic sequencing of SARS-CoV-2, the virus that...
Sep 27, 2022 12:20 PM ET

Pages